Virtual Incision
Lincoln, Nebraska developer of MIRA, a miniaturized robotic-assisted surgery system authorized by the FDA for colectomy and cleared for benign hysterectomy.
Virtual Incision is headquartered in Lincoln, Nebraska, and develops MIRA, a miniaturized robotic-assisted surgery (miniRAS) system meant to make every operating room ready for robotic surgery. Shane Farritor, PhD, is co-founder and chief technology officer, and Jim Alecxih was appointed chief executive in June 2025. The company says it holds more than 200 patents and patent applications. In February 2024 the FDA granted MIRA De Novo authorization for colectomy as the first miniRAS device, and in August 2026 MIRA received 510(k) clearance for benign hysterectomy. A MIRA unit was also sent to the International Space Station in early 2024 to test long-range remote capabilities. In November 2021 Virtual Incision announced a $46 million Series C led by Endeavour Vision and Baird Capital with returning investor Bluestem Capital and others. In September 2023 it extended the Series C by $30 million in a round led by existing investors Bluestem Capital, Endeavour Vision, Baird Capital, cultivate(MD) Capital Funds and PrairieGold Venture Partners with new investors Arboretum Ventures and InVivium Capital, bringing the Series C to $76 million.
- Latest funding
- $30M
- Total funding
- $76M
- Latest valuation
- —
- Founded
- —
- Country
- United States
- Sep 19, 2023Series C extension$30M
- Nov 30, 2021Series C$46M